NCT01004744View on ClinicalTrials.gov

Pre-Surgical Intervention for Targeted Therapies for Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Invasive Breast Cancer
Interventions
DRUG

Anastrozole

1mg PO daily for two weeks prior to scheduled surgery

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

Avon Foundation

OTHER

lead

Columbia University

OTHER

NCT01004744 - Pre-Surgical Intervention for Targeted Therapies for Breast Cancer | Biotech Hunter | Biotech Hunter